VLP Therapeutics
PrivateLast Round
Grant
Dec 11, 2025
Total Funding Raised
$41.7M
Company Overview
VLP Therapeutics operates in Healthcare & Life Sciences and is based in Gaithersburg, Maryland. Its latest recorded funding round was a VC Round in November 2023.
VLP Therapeutics is a biotechnology company that develops next-generation vaccine technologies to treat cancer and infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
VLP Therapeutics Comparables
Compare VLP Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TechnoVax, Inc. | 86% | |
| VLP Biotech, Inc. | 86% | |
| SpyBiotech | 84% |
For institutional investors. Book with your work email.
VLP Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 11, 2025 | ||||
| Grant | Mar 17, 2025 | ||||
| VC Round | Nov 8, 2023 | ||||
| Grant | Oct 3, 2022 | ||||
| Series A Extension | Dec 27, 2021 | ||||
Series A | Mar 15, 2021 |
For institutional investors. Book with your work email.
VLP Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Japan Agency for Medical Research and Development | Grant |
| National Cancer Institute | Grant |
| Phoenixi Co., Ltd. | VC Round |
| Sumitomo Mitsui Trust Bank | VC Round |
| United States Department of Defense | Grant |
| MUFG Bank | VC Round, Series A Extension |
| 株式会社FFGベンチャービジネスパートナーズ | VC Round |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 23, 2026
Monthly visitors increased 48% MoM, reaching 2.4K.
- Apr 18, 2026
Monthly visitors increased 74% MoM.
For institutional investors. Book with your work email.
VLP Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about VLP Therapeutics's valuation, stock price, and market status.
Is VLP Therapeutics a public or private company?
VLP Therapeutics is a private company.
What is the current stock price of VLP Therapeutics?
VLP Therapeutics is a private company, so its shares have no public market price. Caplight tracks VLP Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is VLP Therapeutics worth (valuation)?
Valuation information for VLP Therapeutics is not publicly available.
Can I buy VLP Therapeutics stock?
VLP Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was VLP Therapeutics's last funding round?
VLP Therapeutics's most recent funding round was Grant on December 11, 2025.
Who are the main investors in VLP Therapeutics?
Key investors in VLP Therapeutics include Japan Agency for Medical Research and Development, National Cancer Institute, Phoenixi Co., Ltd., Sumitomo Mitsui Trust Bank, United States Department of Defense.
Will VLP Therapeutics IPO soon?
No public IPO plans have been announced for VLP Therapeutics.
How can I track VLP Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in VLP Therapeutics's shares on secondary markets.